These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 3731202)

  • 21. Tumor necrosis factor in human monocyte-mediated antitumor cytotoxicity.
    Ziegler-Heitbrock HW; Thiel C; Haas JG; Möller A; Riethmüller G
    Nat Immun Cell Growth Regul; 1988; 7(5-6):280-6. PubMed ID: 3221906
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipopolysaccharide (LPS) stimulates fresh human monocytes to lyse actinomycin D-treated WEHI-164 target cells via increased secretion of a monokine similar to tumor necrosis factor.
    Chen AR; McKinnon KP; Koren HS
    J Immunol; 1985 Dec; 135(6):3978-87. PubMed ID: 3905966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heat-shock proteins protect cells from monocyte cytotoxicity: possible mechanism of self-protection.
    Jäättelä M; Wissing D
    J Exp Med; 1993 Jan; 177(1):231-6. PubMed ID: 8418204
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rapid killing of actinomycin D-treated tumour cells by mononuclear phagocytes: reactivity in mouse strains with defective classical tumour cytotoxicity.
    Collota F; Bersani L; Polentarutti N; Mantovani A
    Immunology; 1986 Feb; 57(2):249-53. PubMed ID: 3512426
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Involvement of tumor necrosis factor in cytotoxicity mediated by human monocytes.
    Nissen-Meyer J; Hofsli E; Espevik T; Austgulen R
    Nat Immun Cell Growth Regul; 1988; 7(5-6):266-79. PubMed ID: 3146697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human monocyte-released cytotoxic factor: effect on various cellular functions, and dependency of cytolysis on various metabolic processes.
    Nissen-Meyer J; Kildahl-Andersen O; Austgulen R
    J Leukoc Biol; 1986 Aug; 40(2):121-32. PubMed ID: 3090178
    [TBL] [Abstract][Full Text] [Related]  

  • 27. WEHI-13VAR: a stable and sensitive variant of WEHI 164 clone 13 fibrosarcoma for tumor necrosis factor bioassay.
    Khabar KS; Siddiqui S; Armstrong JA
    Immunol Lett; 1995 May; 46(1-2):107-10. PubMed ID: 7590904
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biochemical and functional characterization of mature progeny purified from a myelomonocytic leukemia cell line.
    Cooper PC; Metcalf D; Burgess AW
    Leuk Res; 1982; 6(3):313-27. PubMed ID: 6956783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synergistic antitumor effects of topoisomerase inhibitors and natural cell-mediated cytotoxicity.
    Utsugi T; Demuth S; Hanna N
    Cancer Res; 1989 Mar; 49(6):1429-33. PubMed ID: 2538225
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cytotoxic effector function of B lymphoblasts.
    Bersani L; Colotta F; Peri G; Mantovani A
    J Immunol; 1987 Jul; 139(2):645-8. PubMed ID: 3496385
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitization of tumor target cells to cytolysis by murine macrophage cytolytic factor by drugs inhibiting DNA, RNA, and protein synthesis.
    Souchek JM; Leroux ME; Klostergaard J
    J Leukoc Biol; 1986 Dec; 40(6):755-68. PubMed ID: 3465837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
    Uchida A; Vánky F; Klein E
    J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of human monocyte killing of tumour cells of antibody raised against an extracellular monocyte cytotoxin.
    Matthews N
    Immunology; 1983 Feb; 48(2):321-7. PubMed ID: 6337089
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Butylated hydroxyanisole inhibits tumor necrosis factor-induced cytotoxicity and arachidonic acid release.
    Brekke OL; Espevik T; Bjerve KS
    Lipids; 1994 Feb; 29(2):91-102. PubMed ID: 8152351
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Killer cell activity of human monoblastic leukemia cells as detected with a monocyte-specific target cell.
    Ziegler-Heitbrock HW; Munker R; Thiel E; Krebs I; Riethmüller G
    Blood; 1985 Jan; 65(1):8-14. PubMed ID: 3155490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effector mechanisms of human monocyte-mediated tumor cytotoxicity in vitro: biochemical, functional, and serological characterization of cytotoxins produced by peripheral blood monocytes isolated by counterflow elutriation.
    Klostergaard J; Foster WA; Hamilton DA; Turpin J; Lopez-Berestein G
    Cancer Res; 1986 Jun; 46(6):2871-5. PubMed ID: 3698012
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor necrosis factor is an important mediator of tumor cell killing by human monocytes.
    Feinman R; Henriksen-DeStefano D; Tsujimoto M; Vilcek J
    J Immunol; 1987 Jan; 138(2):635-40. PubMed ID: 3098851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monocyte mediated cytotoxic activity against melanoma.
    te Velde AA; Figdor CG
    Melanoma Res; 1992; 1(5-6):303-9. PubMed ID: 1422187
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of interferon gamma and tumour necrosis factor alpha in monocyte-mediated cytostasis and cytotoxicity against a human histiocytic lymphoma cell line.
    van de Loosdrecht AA; Ossenkoppele GJ; Beelen RH; Broekhoven MG; Langenhuijsen MM
    Cancer Immunol Immunother; 1992; 34(6):393-8. PubMed ID: 1563017
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cell surface tumor necrosis factor (TNF) accounts for monocyte- and lymphocyte-mediated killing of TNF-resistant target cells.
    Peck R; Brockhaus M; Frey JR
    Cell Immunol; 1989 Aug; 122(1):1-10. PubMed ID: 2502315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.